Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4168417012 | Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4168418019 | Bortezomib 3.5 mg powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4863611000052113 | bortezomib 3,5 mg/injektionsflaska, pulver till injektionsvätska | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product containing only bortezomib in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
| Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | har täljarvärde som visar styrka | 3,5 | false | Inferred relationship | Some | 1 | |
| Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | Bortezomib (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Bortezomib (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR